BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1650504)

  • 1. [A horse with Cushing's disease].
    van der Kolk JH; Klein WR; van der Putten SW; Mol JA
    Tijdschr Diergeneeskd; 1991 Jul; 116(13):670-5. PubMed ID: 1650504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anorexia in a pony with Cushing's disease].
    van der Kolk JH; van Hoorn CJ; van Garderen E; van den Belt AJ
    Tijdschr Diergeneeskd; 1993 May; 118(9):298-300. PubMed ID: 8387700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse.
    Moore JN; Steiss J; Nicholson WE; Orth DN
    Endocrinology; 1979 Mar; 104(3):576-82. PubMed ID: 220013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).
    van der Kolk JH; Kalsbeek HC; van Garderen E; Wensing T; Breukink HJ
    Vet Rec; 1993 Dec; 133(24):594-7. PubMed ID: 8116170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse.
    Horvath CJ; Ames TR; Metz AL; Larson VL
    J Am Vet Med Assoc; 1988 Feb; 192(3):367-71. PubMed ID: 2833479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatotroph and corticotroph pituitary adenoma (double adenoma) in a cat with diabetes mellitus and hyperadrenocorticism.
    Meij BP; van der Vlugt-Meijer RH; van den Ingh TS; Rijnberk A
    J Comp Pathol; 2004; 130(2-3):209-15. PubMed ID: 15003481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid metabolism in horses with hyperadrenocorticism.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    J Am Vet Med Assoc; 1995 Apr; 206(7):1010-2. PubMed ID: 7768707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
    Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E
    Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.
    Orth DN; Nicholson WE
    Endocrinology; 1982 Aug; 111(2):559-63. PubMed ID: 6284484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
    Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
    J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D; Beech J; Cribb A
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic testing for pituitary pars intermedia dysfunction in horses.
    Dybdal NO; Hargreaves KM; Madigan JE; Gribble DH; Kennedy PC; Stabenfeldt GH
    J Am Vet Med Assoc; 1994 Feb; 204(4):627-32. PubMed ID: 8163420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumors of the hypophysis as the cause of both Cushing's syndrome and diabetes insipidus in dogs].
    Bilzer T
    Tierarztl Prax; 1991 Jun; 19(3):276-81. PubMed ID: 1653468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of a pony with Cushing's disease.
    Okada T; Yuguchi K; Kiso Y; Morikawa Y; Nambo Y; Oikawa M; Sasaki F
    J Vet Med Sci; 1997 Aug; 59(8):707-10. PubMed ID: 9300369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanotroph pituitary adenoma in a cat with diabetes mellitus.
    Meij BP; van der Vlugt-Meijer RH; van den Ingh TS; Flik G; Rijnberk A
    Vet Pathol; 2005 Jan; 42(1):92-7. PubMed ID: 15657280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
    Klose M; Jørgensen K; Kristensen LØ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests.
    Orth DN; Holscher MA; Wilson MG; Nicholson WE; Plue RE; Mount CD
    Endocrinology; 1982 Apr; 110(4):1430-41. PubMed ID: 6277607
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.